Q3 financial results are in. With unwavering dedication to advancing Afib treatment options and enhancing post-operative patient care, we have continued to expand our product portfolio and global reach.

Discover the impact of our progress in the full earnings report here: <a href="https://okt.to/OdenYD&quot; target="_blank">https://okt.to/OdenYD</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=earnings&highlightedUpd…; target='_blank'>#earnings</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=FinancialResults&highli…; target='_blank'>#FinancialResults</a>